Skip to main content
GeneAI

What We Offer

GenomicServicesBuiltfortheGCC

End-to-end genomic analysis. From GCC to UK and back.

Every service.Every step.Governed, secured, and delivered.

01Core Service

Genomic Analysis Coordination

World-class sequencing, coordinated end-to-end.

GeneAI coordinates the complete genomic analysis journey — from sample collection at a GCC partner laboratory to clinical-grade sequencing by accredited UK institutions. We manage logistics, chain of custody, documentation, and communication so patients receive world-class analysis without the barriers that have historically made this inaccessible.

Collection Network

Approved GCC laboratories across Bahrain (launch), expanding to Saudi Arabia and UAE in Year 1–2. Each site is vetted against GeneAI collection standard operating procedures.

Analysis Partners

UK genomics laboratories holding UKAS accreditation and ISO 15189 certification. All partners perform clinical-grade next-generation sequencing with validated bioinformatics pipelines.

Service Types

Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Panels, and Carrier Testing. Service selection is guided by the patient's clinical context.

Logistics

Certified medical cold-chain logistics via DHL Medical, World Courier, or Marken. IATA P650-compliant packaging. Real-time chain of custody tracking.

02Intelligence Layer

AI-Assisted Interpretation

Intelligence that surfaces what matters, clearly.

The GeneAI Intelligence Engine performs secondary analysis on structured variant data received from UK laboratory bioinformatics pipelines. It prioritises variants, cross-references published research, and structures findings into a readable report. This is an informational layer — not a diagnostic system. Every output is explicitly labelled and designed to support, not replace, clinical consultation.

Variant Prioritisation

Variants ranked by pathogenicity classification, population frequency in relevant cohorts (including GCC-specific reference data), and published clinical evidence strength.

Research Cross-referencing

Automated cross-referencing against ClinVar, OMIM, gnomAD, and current peer-reviewed literature. Evidence sources cited in every report.

Pattern Recognition

Multi-gene interaction analysis and variant combination flagging — highlighting patterns that may carry cumulative clinical significance for human review.

Explainability

Every AI prioritisation decision includes a reasoning chain. No finding is presented without supporting evidence. Confidence levels are explicit throughout.

03Deliverable

Consolidated Reporting

Results that are genuinely readable.

GeneAI reports are designed to be understood — not just filed. Every report includes a plain-language patient summary, a structured AI findings section with explicit informational labelling, and a full technical appendix for clinical use. Reports are delivered securely to the patient portal and available in PDF and shareable clinical formats.

Patient Summary

Written for a non-clinical reader. Explains what was analysed, what was found, what is significant, and what the recommended next steps are — in plain, accessible language.

AI Findings Section

Structured output from the GeneAI Intelligence Engine — clearly labelled as informational. Variant prioritisation, research references, and pattern observations.

Technical Appendix

Full laboratory variant tables, sequencing quality metrics, methodology notes, and reference database versions. Designed for direct use by clinical consultants.

Portability

Available as structured PDF and in HL7 FHIR-compatible format for integration with clinical systems. Sharable with any clinician the patient chooses to consult.

04Support Service

Optional Referral Pathways

The right specialist, when you want one.

If genomic findings suggest specialist follow-up, GeneAI can match patients to relevant clinical consultants in the GCC or internationally. The referral module is entirely patient-initiated — no one is contacted without your explicit action. Matching is based on specialty alignment, not commercial arrangements.

Specialist Directory

A curated network of clinical consultants with expertise across genomics-adjacent specialties: clinical genetics, oncology, cardiology, neurology, haematology, and rare disease.

Matching Algorithm

Matching considers specialty relevance to your findings, consultation mode (in-person or video), language preference, and geographic availability.

Privacy-First Enquiry

Initial enquiries to specialists are anonymous. You share only what you choose, and only when you choose to share it. Full report sharing requires your explicit action.

Consultation Booking

Appointment scheduling, pre-consultation report sharing, and secure communication are all managed through the patient portal.

05Governance

Data Security & Governance

Your data stays yours, always.

GeneAI operates under a dual-compliance framework — meeting both UK GDPR requirements and GCC Health Authority data standards. All genomic data is encrypted at rest and in transit. Patients retain full data ownership, including the right to deletion. No data is used for research or AI training without explicit consent.

Encryption Standards

AES-256 encryption at rest. TLS 1.3 in transit. Zero-knowledge architecture for genomic data storage ensures raw sequences are never accessible without patient-held keys.

Regulatory Compliance

UK GDPR Article 9 compliant for special category health data. Bahrain PDPL-aligned. Saudi NCA cybersecurity framework aligned for GCC operations.

Data Residency

Patient-selectable data residency: UK-only, GCC-only, or mirrored. Data never leaves the selected jurisdiction without explicit patient consent.

Audit Trail

Immutable access logs for all data interactions. Patients can view who accessed their records, when, and for what purpose — at any time.

06Care Pathway

Patient Support & Navigation

Guidance at every step of the journey.

Genomic results can be complex and emotionally significant. GeneAI provides dedicated patient navigation support — a dedicated point of contact who understands the process, can explain findings in plain language, and can help coordinate next steps. Support is available in English and Arabic.

Patient Navigator

A dedicated care navigator assigned at onboarding. Single point of contact through the entire journey — from sample collection through to report delivery and any follow-up queries.

Results Explanation

Plain-language walkthrough of findings available via secure video call. Navigators are trained to explain genomic concepts clearly without clinical overstatement.

Arabic Language Support

Full Arabic language support across patient communications, report summaries, and navigator consultations. GCC-context cultural competency throughout.

Aftercare Coordination

Following report delivery, navigators can coordinate referral bookings, answer questions about findings, and connect patients with relevant resources and support organisations.

Analysis Packages

Choose Your Analysis

Select the analysis type that matches your clinical need. Not sure? Our intake team will guide you.

Targeted Gene Panel

Essential

Analysis of a defined gene set relevant to a specific clinical question — hereditary cancer, cardiac conditions, or neurological disorders.

Est. 3–4 weeks
  • Targeted panel sequencing (up to 500 genes)
  • Variant calling and primary bioinformatics
  • AI-assisted variant prioritisation
  • Plain-language patient report
  • Technical clinical appendix
Get Started
Most Common

Whole Exome Sequencing

Exome

Comprehensive analysis of all protein-coding regions of the genome — the diagnostic standard for undiagnosed rare disease.

Est. 5–7 weeks
  • Whole exome sequencing (>100x coverage)
  • Full variant calling pipeline
  • ACMG/AMP-aligned variant classification
  • AI-assisted interpretation + research cross-referencing
  • Structured patient report with clinical appendix
  • Optional carrier status analysis
Get Started

Whole Genome Sequencing

Genome

The most comprehensive genomic analysis available — coding and non-coding regions, structural variants, and copy number variation.

Est. 6–8 weeks
  • Whole genome sequencing (>30x coverage)
  • Coding and non-coding variant analysis
  • Structural variant and CNV detection
  • Full AI interpretation suite
  • Comprehensive patient and clinical report
  • Priority specialist matching if indicated
Get Started

Pricing: Customised based on service type, partner configuration, and volume. For B2B institutional pricing, please contact us for a quote.

Compare Plans

Service Comparison

Feature
Essential
Exome
Genome
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Gene Panel
AI Variant Prioritisation
Research Cross-referencing
Plain-Language Report
Technical Appendix
Carrier Status Analysis
Structural Variant Detection
Copy Number Variation
Priority Specialist Matching

Transparent Pricing

Transparent pricing.

No hidden costs.

GeneAI pricing is determined by the analysis package selected and any configured institutional arrangements. There are no referral fees embedded in any price. Patients see exactly what they pay for, and why.

Begin Today

Begin your genomic journey.

© 2026 GeneAI. All Rights Reserved.

GeneAI operates as an information and coordination platform. Not a regulated medical device.

Talk to LAiLAتحدث مع ليلى